Search results
Results from the WOW.Com Content Network
At Johns Hopkins University School of Medicine, he was professor of neuroscience, psychiatry, and behavioral science, and he was the director of the Center for Psychedelic and Consciousness Research. [ 2 ]
Paul R. McHugh, formerly director of the Department of Psychiatry and Behavioral Science at Johns Hopkins, responded as follows in a book review: "The unmentioned fact in The Harvard Psychedelic Club is that LSD, psilocybin, mescaline, and the like produce not a "higher consciousness" but rather a particular kind of "lower consciousness" known ...
Johns Hopkins researchers are studying whether psilocybin from magic mushrooms can help smokers quit. The trial is funded by the NIH. NIH-funded psychedelic trial will study whether hallucinogen ...
Psilocybin session at Johns Hopkins. In the early 2000s, a renewal of interest in the psychiatric use of psychedelics contributed to an increase in clinical research centering on the psychopharmacological effects of these drugs and their subsequent applications.
During one of his last public appearances, Dr. Griffiths sat down with Oprah to discuss the power of psilocybin or "magic mushrooms" to reframe mortality.
Johns Hopkins profile; Multidisciplinary Association for Psychedelic Studies Archived 2005-11-27 at the Wayback Machine - archive of critical articles about Ricaurte ...
Over the past 50 years, research on psychedelics has come a long way from a time when psychedelic albums ruled the charts and psychedelic drugs influenced American counterculture. "I mean, it's ...
Psilocybin session at Johns Hopkins. Psychedelic substances which may have therapeutic uses include psilocybin, LSD, and mescaline. [25] During the 1950s and 1960s, lack of informed consent in some scientific trials on psychedelics led to significant, long-lasting harm to some participants. [25]